Jinho Shin, Dong Hoon Cha, Woo-Hyung Bae, In Hyun Jung, Seung-Pyo Hong, Sang-Hyun Kim, Jun-Young Do, Won Min Hwang, Young Youp Koh, Giuseppe Mancia, Athanasios J Manolis, MinYoung Lee
{"title":"更正:治疗后脉搏率降低,而不是基线脉搏率作为奈比洛尔血压反应的指标:来自现实世界BENEFIT-KOREA研究的一项亚分析。","authors":"Jinho Shin, Dong Hoon Cha, Woo-Hyung Bae, In Hyun Jung, Seung-Pyo Hong, Sang-Hyun Kim, Jun-Young Do, Won Min Hwang, Young Youp Koh, Giuseppe Mancia, Athanasios J Manolis, MinYoung Lee","doi":"10.5646/ch.2025.31.e24","DOIUrl":null,"url":null,"abstract":"<p><p>[This corrects the article e8 in vol. 31, PMID: 40083595.].</p>","PeriodicalId":10480,"journal":{"name":"Clinical Hypertension","volume":"31 ","pages":"e24"},"PeriodicalIF":2.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12230167/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correction: Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study.\",\"authors\":\"Jinho Shin, Dong Hoon Cha, Woo-Hyung Bae, In Hyun Jung, Seung-Pyo Hong, Sang-Hyun Kim, Jun-Young Do, Won Min Hwang, Young Youp Koh, Giuseppe Mancia, Athanasios J Manolis, MinYoung Lee\",\"doi\":\"10.5646/ch.2025.31.e24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>[This corrects the article e8 in vol. 31, PMID: 40083595.].</p>\",\"PeriodicalId\":10480,\"journal\":{\"name\":\"Clinical Hypertension\",\"volume\":\"31 \",\"pages\":\"e24\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12230167/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Hypertension\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5646/ch.2025.31.e24\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Hypertension","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5646/ch.2025.31.e24","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
Correction: Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study.
[This corrects the article e8 in vol. 31, PMID: 40083595.].